Veracyte, Inc.

VCYTNASDAQHealthcare● Active

$47.27

$-1.46(-3.00%)

Market Cap$3.8B

P/E Ratio—

52W High$50.71

52W Low$22.61

Avg Volume1.0M

Open$48.87

Beta1.98

Net Income Financials Revenue

Veracyte, Inc. (VCYT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

VCYT · net income · updated Jun 8, 2026

Core profitability metrics

VCYT · net income · margin · TTM · CAGR

Net income was $66.4M for FY2025 (fiscal year ending 2025-12-31), up 174.9% year-over-year. Net profit margin was 12.8%. Based on available data, Veracyte, Inc. has been profitable since at least 2024.

FY2025 Net Income$66.4M▲ +174.9% YoY

Trailing 12M (TTM)$88.0Mtrailing 4 quarters sum

Net Profit Margin12.8%$66.4M ÷ $517.1M

YoY Change+174.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2024

▸ FMP /income-statement · Annual · VCYT net income history · VCYT profit margin

Annual net income data

VCYT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$66.4M▲ +174.9%12.8%$517.1M

FY2024★ First Profit$24.1M▲ +132.4%5.4%$445.8M

FY2023Loss−$74.4M▼ 103.5%-20.6%$361.1M

FY2022Loss−$36.6M▲ +51.6%-12.3%$296.5M

FY2021Loss−$75.6M▼ 116.5%-34.4%$219.5M

Net income vs peers (Healthcare)

VCYT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Veracyte, Inc.YOU

VCYT

$66.4M+174.9%12.8%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Veracyte, Inc. (VCYT) reported net income of $66.4M for FY2025 (fiscal year ending 2025-12-31), up 174.9% year-over-year. The net profit margin was 12.8% — meaning the company kept $0.13 of every dollar of revenue as profit.

Based on available data, Veracyte, Inc. has been profitable since at least 2024. Net income reached a peak of $66.4M in FY2025. Data available for 15 fiscal years.

Veracyte, Inc.'s net profit margin was 12.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Veracyte, Inc. net worth" — the company's market capitalization is a separate figure from VCYT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

VCYT net income · 5 questions

Veracyte, Inc. is profitable. The company reported net income of $66.4M for FY2025, a net profit margin of 12.8%. Net income was up 174.9% year-over-year. Based on available data, Veracyte, Inc. has been profitable since at least 2024.

is VCYT profitabledoes VCYT make a profitVCYT profitabilityVCYT profitable company

▸ Source: FMP /income-statement · GAAP · Veracyte, Inc. · Veracyte, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026